The independent source for health policy research, polling, and news.
281 - 300 of 388 Results
Last month, U.S. Surgeon General Jerome Adams urged more Americans to carry and learn to use naloxone, which can save someone from an opioid overdose. But the drug, brand-name Narcan, can be difficult to get and expensive.
Research is just beginning on infants born with neonatal abstinence syndrome, and doctors are optimistic that normal development is possible. Monitoring the families and making sure parents are treated for addiction is key.
A device called the Bridge is supposed to mitigate the misery of withdrawal sickness, but scientific evidence doesn't yet show that it works.
About 2,000 Californians died of opioid overdoses in 2016, but access to medications that treat addiction is limited in some parts of the state.
KHN’s newsletter editor, Brianna Labuskes, wades through hundreds of health articles from the week so you don’t have to.
Surgeon General Jerome Adams urged more people to carry the drug naloxone, a lifesaving treatment for opioid overdoses. But this policy is tricky to implement.
KHN's newsletter editor, Brianna Labuskes, wades through hundreds of health articles from the week so you don't have to.
First of all, make sure you have an overdose reversal drug handy. Then prepare for years of vigilance and long-term medication.
Standards for how to investigate and report on overdoses vary widely across states and counties. As a result, opioid overdose deaths often go overlooked in the data reported to the federal government.
The legislation is intended to curb schemes in which some treatment providers sign patients up for private plans, pay their premiums and then rake in profits from inflated claims.
Opioid overdoses and related deaths are still climbing, U.S. statistics show. Teasing out which overdoses are intentional can be hard, but is important for treatment, doctors say.
President Trump, speaking Monday, called for a tough-on-crime federal approach. Meanwhile, on Capitol Hill, legislative strategies to combat this pressing public health problem are gaining momentum, but experts are not certain these approaches will make a difference.
Purdue Pharma, whose signature product helped fuel the opioid epidemic, now wants to help treat it — or at least salvage its own reputation.
An addiction-treatment physician fatally shot a troubled ex-Marine after the man pummeled him inside his California office, police records show. The tragedy illustrates how the limited number of clinics available to prescribe buprenorphine, a drug that all but erases opioid withdrawal, can become crowded, chaotic and dangerous.
The Trump administration has talked about prioritizing the opioid crisis, but states have seen little in the way of new resources. And, in some states, getting into treatment is becoming even harder.
The collaboration known as ALTO, Alternatives to Opioids, set out to reduce opioid doses in the emergency room by 15 percent. It managed a 36 percent reduction instead.
Fentanyl, a significant cause of overdoses and deaths across the country, has begun showing up in California street drugs. State health officials have responded with a bold but controversial policy: paying for test strips so users can check their stash.
Andrey Ostrovsky, who until last month was chief medical officer for Medicaid, quit his job so he could more directly fight the stigma of drug addiction.
Philadelphia officials gave the OK to establishing safe-injection sites for drug users. But it's unclear where the sites would be located and who would fund and operate them.
© 2026 KFF